SAN DIEGO--(BUSINESS WIRE)--Sept. 5, 2006--Inovio Biomedical Corporation (AMEX:INO) announced today the presentation of a report summarizing results of a wound healing study conducted in collaboration with scientists at the University of Arizona Cancer Center. The data, presented at the Gordon Research Conference for Bioelectrochemistry in Aussois, France, September 3-8, 2006, demonstrates that wound healing following surgical incision is not significantly influenced by Inovio's electroporation-based SECTA therapy. This study was conducted to evaluate a potential use of SECTA, for the treatment of solid tumor margins following surgical resection of cancerous tumors. The positive result of this study is a validating step for this new application, which could potentially expand Inovio's market opportunity to include many surgical procedures for solid tumors.
